Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline
about
Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists.The Canadian Bladder Cancer Network: efforts to improve patient care.Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy.Cisplatin-based first-line therapy for advanced urothelial carcinoma after previous perioperative cisplatin-based therapyPredictors of referral for neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer and changes in practice over timeMultimodal therapies for muscle-invasive urothelial carcinoma of the bladderNeoadjuvant paradigm for accelerated drug development: an ideal model in bladder cancer.Improving the outcome of patients with muscle invasive urothelial carcinoma of the bladder with neoadjuvant gemcitabine/cisplatin chemotherapy: A single institution experience.MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status.Using clinical practice guidelines in our own backyard: treating our patients with bladder cancer.Invasive bladder cancer: ignoring the data.[Muscle invasive bladder cancer after radical cystectomy. Prognostic factors of adjuvant chemotherapy].
P2860
Q34435978-3D2523D6-F042-4783-8B14-26BEDB1B05E4Q35014738-2B05BDD4-6C83-4BD2-8B91-4DB7F10C04C5Q35109085-D0121E42-B891-461D-A0EF-DE00C0BC23FAQ35771672-8EB474DC-0F10-4812-997A-0A6CD7F2C46AQ35956231-AA90ABC9-5BE2-403C-BAA2-1AC93EC02507Q36973553-1E75E695-FA4D-4605-8A10-8247747A506FQ37128756-D8F83ADC-7CDE-462F-A11C-97D392C77AF2Q37726901-FAC6D9AF-D35F-45E1-9DE9-AECAE4BED61CQ39518813-3D846AD7-34BD-4431-B623-E698A8140974Q41874190-CC716BBD-0DA5-48A1-94C4-4BFB4DA374F7Q42575248-512CF174-B298-478A-B1B7-E59DB45387C7Q43913506-00447AAE-38E3-4ABE-96E6-08E163E0B2CF
P2860
Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Referral and treatment rates o ...... a clinical practice guideline
@ast
Referral and treatment rates o ...... a clinical practice guideline
@en
Referral and treatment rates o ...... a clinical practice guideline
@nl
type
label
Referral and treatment rates o ...... a clinical practice guideline
@ast
Referral and treatment rates o ...... a clinical practice guideline
@en
Referral and treatment rates o ...... a clinical practice guideline
@nl
prefLabel
Referral and treatment rates o ...... a clinical practice guideline
@ast
Referral and treatment rates o ...... a clinical practice guideline
@en
Referral and treatment rates o ...... a clinical practice guideline
@nl
P2093
P2860
P356
P1476
Referral and treatment rates o ...... a clinical practice guideline
@en
P2093
Adrian S Fairey
Brendan J W Miles
Daygen Finch
Eric P Estey
Kiril Trpkov
Michael Eliasziw
Peter Venner
P2860
P304
P356
10.5489/CUAJ09134
P577
2010-08-01T00:00:00Z